BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2002
View Archived Issues
Highly effective antinephritic agent derived from linomide
Read More
Large study compares cannabinoid and progesterone in cancer-associated anorexia
Read More
Optimal glycemic control obtained on mealtime repaglinide
Read More
Neuroprotective effects of an MLK-targeting indolocarbazole analogue
Read More
Available data on AWD-12-281, a new respiratory therapeutic, summarized
Read More
Abgenix reports on Q4 and year-end 2001 product development
Read More
BioCryst announces fourth-quarter results
Read More
Icos summarizes 2001 highlights
Read More
CVT-2759 more selective than adenosine in attenuating catecholamine-induced arrhythmia
Read More
Progress reported by North American Scientific on molecular imaging agent
Read More
Alesse approved by Canadian authorities for treatment of acne
Read More
Chugai cleared to resume clinical trials of GM-611
Read More
InterMune relaunches Infergen for hepatitis C infections
Read More
Phase IIb trial of ATL-1251 in mixed-symptom IBS cleared by U.K. authorities
Read More
Amersham Health and Pfizer collaborate to link early disease diagnosis and treatment
Read More
J&J selects validated drug targets from oncology collaboration with Rigel
Read More
Agouron terminates HIV target collaboration with PPD Discovery
Read More
Aromatic carboxamides effective as orexin-1 receptor antagonists
Read More
Schering-Plough discloses use and preparation of thrombin and CB2 receptor antagonists
Read More
Novel heterocyclic compounds with potential utility in neuropathies, etc.
Read More
Integrin receptor inhibitors identified at Merck KGaA
Read More
Boehringer Ingelheim prepares non-nucleoside compounds that inhibit HIV reverse transcriptase
Read More
Researchers at Senju claim chymase inhibitors for cardiovascular disease Rx
Read More